These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 4203640)

  • 41. [Prevention of Rh immunization in Finland. Results obtained in a two-year national anti-D programme].
    Eklund J; Nevanlinna HR
    Duodecim; 1971; 87(10):861-6. PubMed ID: 4998010
    [No Abstract]   [Full Text] [Related]  

  • 42. Prevention of Rh immunization: some failures and the possibility of overcoming them.
    Chown B
    Ann Ostet Ginecol Med Perinat; 1970 Jul; 92(7):440-6. PubMed ID: 5003522
    [No Abstract]   [Full Text] [Related]  

  • 43. [Problems in anti-rhesus (D) immunoprophylaxis].
    Bennebroek Gravenhorst J; Overbeeke MA; van Dijk BA
    Ned Tijdschr Geneeskd; 1984 May; 128(21):1005-9. PubMed ID: 6429554
    [No Abstract]   [Full Text] [Related]  

  • 44. [Practical experiences with the anti-D-IgG prevention of Rh-immunization].
    Bergmann H; Leinzinger E; Pazdernik I; Haider M
    Wien Med Wochenschr; 1969 Jan; 119(1):9-12. PubMed ID: 4975236
    [No Abstract]   [Full Text] [Related]  

  • 45. Antenatal anti-D immunoglobulin.
    Lancet; 1983 Sep; 2(8352):734. PubMed ID: 6136859
    [No Abstract]   [Full Text] [Related]  

  • 46. [Use of anti-Rh-immunoglobulin in abortions].
    Aleskerov GS
    Akush Ginekol (Mosk); 1977 Nov; (11):40-3. PubMed ID: 415634
    [No Abstract]   [Full Text] [Related]  

  • 47. Prevention of Rh sensitization. Report of a WHO Scientific Group.
    World Health Organ Tech Rep Ser; 1971; 468():3-36. PubMed ID: 4999558
    [No Abstract]   [Full Text] [Related]  

  • 48. [Prevention of Rhesus-sensitization by intravenous administration of immunoglobulin G anti-D. II. General prevention using low doses of IgG anti-D, adapted to the extent of fetomaternal transfusion].
    Börner P; Deicher H; Ghani G; Geldmacher H; Kayser D; Kahnt P; Klang D; Klaus H; Marks V; Nehawandian OA
    Geburtshilfe Frauenheilkd; 1971 Oct; 31(10):911-23. PubMed ID: 5002413
    [No Abstract]   [Full Text] [Related]  

  • 49. [Our preliminary experience in the field of serum prevention of anti-HDN hemolytic disease of the newborn by means of anti-D immunoglobulins].
    Arrotta U; Cardinale F; Sideri L
    Minerva Ginecol; 1972 Dec; 24(12):619-26. PubMed ID: 4211544
    [No Abstract]   [Full Text] [Related]  

  • 50. [Evaluation of the Center for Rh-negative Mothers. Hospital Paula Jaraquemada (3 years)].
    Krug A; Bianchi R; Pérez N; Ilabaca G; Farías S; Rojas E
    Rev Chil Obstet Ginecol; 1981; 46(4):206-14. PubMed ID: 6099901
    [No Abstract]   [Full Text] [Related]  

  • 51. [Incidence of materno-fetal isoimmunization against the Rh factor (D)].
    Marmorino C
    Minerva Med; 1972 Dec; 63(86):4699-707. PubMed ID: 4629911
    [No Abstract]   [Full Text] [Related]  

  • 52. [Anti-D-prevention within the scope of a regional work-community].
    Luboldt W; Lohmeyer H; Schmolling E; Hoize J; Neumann H
    Med Klin; 1970 May; 65(22):1082-8. PubMed ID: 5000118
    [No Abstract]   [Full Text] [Related]  

  • 53. Epidemiology of Rh hemolytic disease of the newborn, United States, 1960-1979.
    Adams MM; Gustafson J
    Prog Clin Biol Res; 1981; 70():213-7. PubMed ID: 6273934
    [No Abstract]   [Full Text] [Related]  

  • 54. Incidence of Rh immunization in primigravidae and risk of immunization in multiparae.
    Lundsgaard A
    Ann Ostet Ginecol Med Perinat; 1970 Jul; 92(7):450-1. PubMed ID: 5003524
    [No Abstract]   [Full Text] [Related]  

  • 55. [Prevention of Rh sensitization using immunoglobulin anti-D].
    Stampfli K; de Muralt G
    Schweiz Med Wochenschr; 1969 Oct; 99(42):1519-21. PubMed ID: 4983123
    [No Abstract]   [Full Text] [Related]  

  • 56. [The prevention of rhesus immunization with anti-rhesus (D) immunoglobulin. Report of a clinical study carried out in Dutch hospitals].
    Dudok De Wit C; Borst-Eilers E; van der Weerdt CM; Kloosterman GJ
    Ned Tijdschr Geneeskd; 1968 Dec; 112(52):2345-51. PubMed ID: 4974070
    [No Abstract]   [Full Text] [Related]  

  • 57. [Rh immunization].
    Broman B
    Lakartidningen; 1972 Dec; 69():Suppl 4:89-91. PubMed ID: 4632636
    [No Abstract]   [Full Text] [Related]  

  • 58. [Screening of irregular antibodies in pregnancy].
    Bolis PF; Zara C
    Arch Ostet Ginecol; 1972; 77(5):345-51. PubMed ID: 4219579
    [No Abstract]   [Full Text] [Related]  

  • 59. Rh hemolytic disease of the newborn: its cause and prevention.
    Pollack W
    Prog Clin Biol Res; 1981; 70():185-302. PubMed ID: 6273932
    [No Abstract]   [Full Text] [Related]  

  • 60. Rh haemolytic disease of the newborn: the role of the laboratory.
    Tovey LA
    Med Lab Sci; 1982 Jul; 39(3):297-303. PubMed ID: 6813628
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.